Riskpilot← Back to searchSign inGet full accessCONSULTA AS
ASActiveOrg 993544078Strandveien 36C, 3530 RøyseBuying and selling of own real estate · NACE 6811Est. 20090 employees
Revenue 2025
NOK 1,3M
+653% vs 2024
EBITDA margin
97.4%
+725% vs 2024
Equity ratio
49.3%
Financial strength
Net profit 2025
NOK 1M
+752% vs 2024
| Revenue | NOK 1,3M | +653% |
| EBITDA | NOK 1,3M | +725% |
| Net profit | NOK 1M | +752% |
| Total assets | NOK 2M | -23% |
| Equity | NOK 1M | +15685% |
| Employees | 0 | — |
Legal name
CONSULTA AS
Org number
993544078
Legal form
Aksjeselskap
NACE code
6811 · Buying and selling of own real estate
Founded
18. februar 2009
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Kjøp, salg, utleie og investering i fast eiendom og hva derved er forbundet, samt investering og deltagelse i andre selskap. Investering i næringsvirksomhet, herunder aksjer og andeler, samt deltagelse i andre selskaper med lignende virksomhet. Konsulenttjenester investering, handel med, og trading av edle metaller, kryptovalutaer, utility og service tokens, samt deltagelse i andre selskaper med liknende virksomhet. Helsetjenester innen fastlegeordning,allmennmedisin og legevakt. Forebyggende helsearbeid, helsekontroller ogrådgivningstjenester. Planlegging og gjennomføring av medisinsk beredskap i tråd medoffentlige krav og idrettsforbundets retningslinjer.
Address
Strandveien 36C, 3530 Røyse
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 419 | 83 | 16 | 171 | 1 286 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 395 | 71 | 5 | 152 | 1 252 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 395 | 71 | 5 | 152 | 1 252 |
| Net financials | −55 | −10 | −42 | −34 | −13 |
| Profit before tax | 339 | 62 | −37 | 117 | 1 239 |
| Tax | −0 | −0 | −0 | −0 | 239 |
| Net profit | 339 | 62 | −37 | 117 | 1 000 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 821 | 3 839 | 3 927 | 2 647 | 2 040 |
| Equity | −136 | −74 | −111 | 6 | 1 006 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 957 | 3 914 | 4 038 | 2 640 | 1 000 |
| Total debt | 3 957 | 3 914 | 4 038 | 2 640 | 1 034 |
EBITDA margin
97.4%
This company
15.8%
Market median
+516% vs market
20212025
Equity ratio
49.3%
This company
38.2%
Market median
+29% vs market
20212025
Return on equity
99.4%
This company
18.4%
Market median
+440% vs market
20212025
Net profit margin
77.8%
This company
8.1%
Market median
+860% vs market
20212025
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
20212025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DW Deputy Member | Deputy Member | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2009 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CONSULTA AS 
PURE SKIN MEDICAL ASBoard members of CONSULTA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David William Kandela | Deputy Member | 0 companies |
| Gary Kandela | Chairman | 0 companies |